Abstract:Background: Telomere has been recognized as a biomarker of accelerating aging, and telomere length (TL) shortening is closely related to diverse chronic illnesses. Human serum metabolites have demonstrated close correlations with TL maintenance or shortening in observational studies. Nevertheless, little is known about the underlying pathological mechanisms, and Mendelian randomization (MR) analysis of serum metabolites may provide a more comprehensive understanding of the potential biological process. Methods: We employed a two-sample MR analysis method to assess the causal links between 486 serum metabolites and TL. We applied the inverse-variance weighted (IVW) approach as our primary analysis, and to assure the stability and robustness of our results, additional analysis methods including the weighted median, MR-Egger, and weighted mode were conducted. MR-Egger intercept test was utilized to detect the pleiotropy. Cochran's Q test was implemented to quantify the extent of heterogeneity. Furthermore, the pathway analysis was conducted to identify potential metabolic pathways. Results: We identified 11 known blood metabolites associated with TL. Among these metabolites, four were lipid (taurocholate, dodecanedioate, 5,8-tetradecadienoate, and 15-methylpalmitate), one amino acid (levulinate (4-oxovaleate)), one carbohydrate (lactate), one nucleotide (pseudouridine), one energy (phosphate), and three xenobiotics (2-hydroxyacetaminophen sulfate, paraxanthine, and ergothioneine). The known protective metabolites included levulinate (4-oxovaleate), dodecanedioate, 5,8-tetradecadienoate, lactate, phosphate, paraxanthine, and ergothioneine. Multiple metabolic pathways have been identified as being implicated in the maintenance of telomere length. Conclusion: Our MR analysis provided suggestive evidence supporting the causal relationships between 11 identified blood metabolites and TL, necessitating further exploration to clarify the mechanisms by which these serum metabolites and metabolic pathways may affect the progression of telomeres.

Breaking down causes, consequences, and mediating effects of telomere length variation on human health

Breaking down causes, consequences, and mediating effects of age-related telomere shortening on human health

Polygenic basis and biomedical consequences of telomere length variation

Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences

Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Investigating the association between blood metabolites and telomere length: A mendelian randomization study

Identifying potential causal effects of telomere length on health outcomes: A phenome-wide investigation and Mendelian randomization study

Investigating the impact of metabolic syndrome traits on telomere length: a Mendelian randomization study

Telomere length: how the length makes a difference

Epigenome-wide association study of leukocyte telomere length.

Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection

Genetic liability to human serum metabolites is causally linked to telomere length: insights from genome-wide Mendelian randomization and metabolic pathways analysis

The Importance of Telomere Shortening for Atherosclerosis and Mortality

Telomeres and Telomere Length: A General Overview

Abstract 2745: Genetic Determinants of Telomere Length – a Genome Wide Association Study

Proteomic Mendelian randomization to identify protein biomarkers of telomere length

Telomere length and brain imaging phenotypes in UK Biobank

Causal Association of Telomere Length and Loss of Bone: a Directional Mendelian Randomization Study of Multi-Outcomes

Exploring the Causal Pathway from Telomere Length to Alzheimer’s Disease: an Update Mendelian Randomization Study

Validation of human telomere length multi-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as human telomere length regulation genes